136 related articles for article (PubMed ID: 9084458)
1. Pharmacokinetics and pharmacodynamics of cetirizine in infants and toddlers.
Spicák V; Dab I; Hulhoven R; Desager JP; Klánová M; de Longueville M; Harvengt C
Clin Pharmacol Ther; 1997 Mar; 61(3):325-30. PubMed ID: 9084458
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of cetirizine in 2- to 6-year-old children.
Pariente-Khayat A; Rey E; Dubois MC; Vauzelle-Kervroedan F; Pons G; D'athis P; Murat II; Pinelli ME; Saint-Maurice C; Olive G
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):340-4. PubMed ID: 7582385
[TBL] [Abstract][Full Text] [Related]
3. A pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effects of cetirizine.
Urien S; Tillement JP; Ganem B; Kuch MD
Int J Clin Pharmacol Ther; 1999 Oct; 37(10):499-502. PubMed ID: 10543317
[TBL] [Abstract][Full Text] [Related]
4. Cetirizine in horses: pharmacokinetics and pharmacodynamics following repeated oral administration.
Olsén L; Bondesson U; Broström H; Tjälve H; Ingvast-Larsson C
Vet J; 2008 Aug; 177(2):242-9. PubMed ID: 17581764
[TBL] [Abstract][Full Text] [Related]
5. Hydroxyzine and cetirizine pharmacokinetics and pharmacodynamics after oral and intravenous administration of hydroxyzine to healthy dogs.
Bizikova P; Papich MG; Olivry T
Vet Dermatol; 2008 Dec; 19(6):348-57. PubMed ID: 18980631
[TBL] [Abstract][Full Text] [Related]
6. Cetirizine in horses: pharmacokinetics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Bondesson U; Broström H; Tjälve H; Larsson P
J Vet Pharmacol Ther; 2007 Jun; 30(3):194-200. PubMed ID: 17472650
[TBL] [Abstract][Full Text] [Related]
7. The comparative pharmacokinetics of H1-receptor antagonists.
Simons FE; Simons KJ; Chung M; Yeh J
Ann Allergy; 1987 Dec; 59(6 Pt 2):20-4. PubMed ID: 2892445
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine-induced cutaneous responses in healthy adult volunteers.
Devalia JL; De Vos C; Hanotte F; Baltes E
Allergy; 2001 Jan; 56(1):50-7. PubMed ID: 11167352
[TBL] [Abstract][Full Text] [Related]
9. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
Lefebvre RA; Rosseel MT; Bernheim J
Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
[TBL] [Abstract][Full Text] [Related]
10. Levocetirizine: pharmacokinetics and pharmacodynamics in children age 6 to 11 years.
Simons FE; Simons KJ
J Allergy Clin Immunol; 2005 Aug; 116(2):355-61. PubMed ID: 16083790
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of cetirizine in healthy cats.
Papich MG; Schooley EK; Reinero CR
Am J Vet Res; 2008 May; 69(5):670-4. PubMed ID: 18447800
[TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic evaluation of the second-generation H1-receptor antagonist cetirizine in very young children.
Desager JP; Dab I; Horsmans Y; Harvengt C
Clin Pharmacol Ther; 1993 Apr; 53(4):431-5. PubMed ID: 8477559
[TBL] [Abstract][Full Text] [Related]
13. Dermal objective pharmacodynamic profile of cetirizine and epinastine: two controlled, randomised, double-blind, crossover studies.
Leroy T; van Neste D
Int J Clin Pract; 2002 Oct; 56(8):568-73. PubMed ID: 12425364
[TBL] [Abstract][Full Text] [Related]
14. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of levocetirizine in very young children: the pediatricians' perspective.
Simons FE;
Pediatr Allergy Immunol; 2005 Mar; 16(2):97-103. PubMed ID: 15787865
[TBL] [Abstract][Full Text] [Related]
16. Cetirizine pharmacokinetics and pharmacodynamics in primary biliary cirrhosis.
Simons FE; Watson WT; Minuk GY; Simons KJ
J Clin Pharmacol; 1993 Oct; 33(10):949-54. PubMed ID: 7693767
[TBL] [Abstract][Full Text] [Related]
17. Levocetirizine in 1-2 year old children: pharmacokinetic and pharmacodynamic profile.
Cranswick N; Turzíkova J; Fuchs M; Hulhoven R
Int J Clin Pharmacol Ther; 2005 Apr; 43(4):172-7. PubMed ID: 15966463
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
Deschamps C; Dubruc C; Mentre F; Rosenzweig P
Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers.
Russell T; Stoltz M; Weir S
Clin Pharmacol Ther; 1998 Dec; 64(6):612-21. PubMed ID: 9871426
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of histamine-induced wheal, flare and doppler laser flowmetry during long-term (180 days) of cetirizine 10 mg per day treatment].
Kruszewski J; Kłos K; Sułek K
Pol Merkur Lekarski; 2005 Dec; 19(114):758-60. PubMed ID: 16521417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
